Successes and Challenges of HIV Treatment Programs in Haiti: Aftermath of the Earthquake

Overview

Journal HIV Ther

Publisher Future Medicine

Specialty Infectious Diseases

Date 2011 Jan 4

PMID 21197385

Citations 19

Authors

S Koenig

Lc Ivers

S Pace

R Destine

F Leandre

R Grandpierre

J Mukherjee

Pe Farmer

Jw Pape

Affiliations

Soon will be listed here.

Abstract

Haiti's HIV/AIDS program is one of the most successful in the world, with a declining HIV prevalence, and treatment outcomes that rival those of industrialized nations. It is now on the way to providing universal treatment for HIV/AIDS nationwide. This success is tied to a strong foundation for HIV care that was in place before external funding became available that includes national guidelines prepared by the Ministry of Health, political commitment at the highest levels of government, non-governmental organizations that had been providing high quality care in Haiti for decades, and the assistance of the Global Fund to Fight AIDS, TB, and Malaria, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and other private donors.While the challenges of human resource shortages, widespread poverty, and limited infrastructure cannot be overstated, these are being addressed through the provision of integrated, comprehensive services. Haiti's successful treatment models are being duplicated around the world.

Citing Articles

The impact of earthquakes in Latin America on the continuity of HIV care: A retrospective observational cohort study.

Gorsline C, Lotspeich S, Belaunzaran-Zamudio P, Mejia F, Cortes C, Crabtree-Ramirez B Public Health Pract (Oxf). 2024; 7:100479.

PMID: 38405231 PMC: 10883833. DOI: 10.1016/j.puhip.2024.100479.

Patient and health worker perspectives on quality of HIV care and treatment services in Haiti.

Puttkammer N, Demes J, Dervis W, Chery J, Elusdort J, Haight E BMC Health Serv Res. 2023; 23(1):66.

PMID: 36683038 PMC: 9869625. DOI: 10.1186/s12913-023-09041-2.

"" or ""? Exploring consequences of external shocks on community health systems in Haiti.

Sripad P, Casseus A, Kennedy S, Isaac B, Vissieres K, Warren C J Glob Health. 2021; 11:07004.

PMID: 33763218 PMC: 7956116. DOI: 10.7189/jogh.11.07004.

Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America.

Somerville K, Jenkins C, Carlucci J, Person A, Machado D, Luque M J Acquir Immune Defic Syndr. 2021; 87(3):993-1001.

PMID: 33675618 PMC: 8192432. DOI: 10.1097/QAI.0000000000002678.

Patient-Provider Communication and Information, Motivation, and Behavioral Skills in HIV-Positive Adults Initiating Antiretroviral Therapy in Haiti.

Ramaiya M, Haight E, Simoni J, Chery J, Dervis W, Genna W J Int Assoc Provid AIDS Care. 2020; 19:2325958220952631.

PMID: 32924764 PMC: 7493277. DOI: 10.1177/2325958220952631.

References

Deschamps M, Fitzgerald D, Pape J, Johnson Jr W . HIV infection in Haiti: natural history and disease progression. AIDS. 2000; 14(16):2515-21. DOI: 10.1097/00002030-200011100-00014. View

Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G . Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005; 353(22):2325-34. DOI: 10.1056/NEJMoa051908. View

Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter L, Kim J . Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull World Health Organ. 2002; 79(12):1145-51. PMC: 2566712. View

Pape J, Liautaud B, Thomas F, Mathurin J, St Amand M, Boncy M . Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N Engl J Med. 1983; 309(16):945-50. DOI: 10.1056/NEJM198310203091603. View

Farmer P, Leandre F, Mukherjee J, Claude M, Nevil P, Smith-Fawzi M . Community-based approaches to HIV treatment in resource-poor settings. Lancet. 2001; 358(9279):404-9. DOI: 10.1016/s0140-6736(01)05550-7. View

Pape J, Jean S, Ho J, Hafner A, Johnson Jr W . Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993; 342(8866):268-72. DOI: 10.1016/0140-6736(93)91817-6. View

Noel F, Mehta S, Zhu Y, Rouzier P, Marcelin A, Shi J . Improving outcomes in infants of HIV-infected women in a developing country setting. PLoS One. 2008; 3(11):e3723. PMC: 2580032. DOI: 10.1371/journal.pone.0003723. View

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L . Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006; 367(9519):1335-42. DOI: 10.1016/S0140-6736(06)68580-2. View

DeHovitz J, Pape J, Boncy M, Johnson Jr W . Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1986; 315(2):87-90. DOI: 10.1056/NEJM198607103150203. View

10.

Walton D, Farmer P, Lambert W, Leandre F, Koenig S, Mukherjee J . Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. J Public Health Policy. 2004; 25(2):137-58. DOI: 10.1057/palgrave.jphp.3190013. View

11.

Deschamps M, Noel F, Bonhomme J, Devieux J, Saint-Jean G, Zhu Y . Prevention of mother-to-child transmission of HIV in Haiti. Rev Panam Salud Publica. 2009; 25(1):24-30. DOI: 10.1590/s1020-49892009000100004. View

12.

Braitstein P, Brinkhof M, Dabis F, Schechter M, Boulle A, Miotti P . Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006; 367(9513):817-24. DOI: 10.1016/S0140-6736(06)68337-2. View

13.

Hymes K, Cheung T, Greene J, Prose N, Marcus A, Ballard H . Kaposi's sarcoma in homosexual men-a report of eight cases. Lancet. 1981; 2(8247):598-600. DOI: 10.1016/s0140-6736(81)92740-9. View

14.

Jean S, Pape J, Verdier R, Reed G, Hutto C, Johnson Jr W . The natural history of human immunodeficiency virus 1 infection in Haitian infants. Pediatr Infect Dis J. 1999; 18(1):58-63. DOI: 10.1097/00006454-199901000-00014. View

15.

Joseph P, Severe P, Ferdinand S, Goh K, Sola C, Haas D . Multidrug-resistant tuberculosis at an HIV testing center in Haiti. AIDS. 2006; 20(3):415-8. DOI: 10.1097/01.aids.0000206505.09159.9a. View

16.

Keet I, Lee F, van Griensven G, Lange J, Nahmias A, Coutinho R . Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med. 1990; 66(5):330-3. PMC: 1194551. DOI: 10.1136/sti.66.5.330. View

17.

Boulos R, Halsey N, Holt E, Ruff A, Brutus J, Quinn T . HIV-1 in Haitian women 1982-1988. The Cite Soleil/JHU AIDS Project Team. J Acquir Immune Defic Syndr (1988). 1990; 3(7):721-8. View

18.

Moskowitz L, Kory P, Chan J, Haverkos H, Conley F, HENSLEY G . Unusual causes of death in Haitians residing in Miami. High prevalence of opportunistic infections. JAMA. 1983; 250(9):1187-91. View

19.

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

20.

Charles M, Noel F, Leger P, Severe P, Riviere C, Beauharnais C . Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bull World Health Organ. 2009; 86(12):970-7. PMC: 2649577. DOI: 10.2471/blt.07.050120. View